Caplin Point Laboratories Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20	Mar ' 19

Sources of funds

Owner's fund

Equity share capital

15.18

15.16

15.13

15.13

15.13

Share application money

15.37

8.96

14.80

9.44

6.86

Preference share capital

-

-

-

-

-

Reserves & surplus

1,109.36

906.53

728.75

575.34

410.06

Loan funds

Secured loans

-

-

0.01

0.28

0.29

Unsecured loans

-

-

-

-

-

Total

1,139.91

930.65

758.69

600.19

432.33

Uses of funds

Fixed assets

Gross block

279.61

263.73

264.08

227.01

179.13

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

122.76

101.27

81.39

60.08

41.36

Net block

156.85

162.46

182.69

166.93

137.77

Capital work-in-progress

42.68

2.60

1.36

3.77

8.62

Investments

434.14

264.70

149.18

195.77

168.25

Net current assets

Current assets, loans & advances

669.51

624.40

527.78

324.86

224.69

Less : current liabilities & provisions

163.27

123.51

102.32

91.14

106.99

Total net current assets

506.24

500.89

425.46

233.72

117.70

Miscellaneous expenses not written

-

-

-

-

-

Total

1,139.91

930.65

758.69

600.19

432.33

Notes:

Book value of unquoted investments

-

-

0.70

5.42

0.29

Market value of quoted investments

21.00

-

11.20

60.56

69.66

Contingent liabilities

84.60

36.81

44.61

26.56

74.63

Number of equity sharesoutstanding (Lacs)

759.03

757.89

756.43

756.43

756.30